Document is current
Any future updates will be listed below
-
Authors
Widdess, Marcus A.
Pakidi, Anastasia
Metcalfe, Hannah J.
Chan, H. T. Claude
Inzhelevskaya, Tatyana
Penfold, Chris A.
Mockridge, C. Ian
Booth, Steven G.
James, Sonya https://orcid.org/0000-0002-0032-5935
Lim, Sean H. https://orcid.org/0000-0002-2768-4858
Beers, Stephen A. https://orcid.org/0000-0002-3765-3342
Cragg, Mark S. https://orcid.org/0000-0003-2077-089X
Al-Shamkhani, Aymen https://orcid.org/0000-0003-0727-4189
-
Funding
Funding for this research was provided by:
Cancer Research UK (DRCDDRPGMApr2020\100005)
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 11 December 2025
First Online: 20 December 2025
Competing interests
: A.Al-S. and S.H.L. are inventors on patents pertaining to the generation and therapeutic use of agonist anti-CD27 antibodies and have received research funding from Celldex Therapeutics in relation to anti-CD27 antibodies. The remaining authors declare no competing interests.
